Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125229692 | 12522969 | 2 | F | 201606 | 20160627 | 20160701 | 20160707 | EXP | PHEH2016US015998 | NOVARTIS | 69.04 | YR | F | Y | 81.10000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125229692 | 12522969 | 1 | PS | FEMARA | LETROZOLE | 1 | Oral | 2.5 MG, QD | 20726 | 2.5 | MG | TABLET | QD | ||||||
| 125229692 | 12522969 | 2 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 5 MG, (1 TO 2 TABLETS NIGHTLY AS NEEDED) | 0 | 5 | MG | ||||||||
| 125229692 | 12522969 | 3 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | 800/160MG TABLET ONE WEEK PESCRIPTION | 0 | ||||||||||
| 125229692 | 12522969 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 500 MG, TID | 0 | 500 | MG | TID | |||||||
| 125229692 | 12522969 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 125229692 | 12522969 | 6 | C | LOPID | GEMFIBROZIL | 1 | 600 MG, BID | 0 | 600 | MG | BID | ||||||||
| 125229692 | 12522969 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | 81 MG, QD | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125229692 | 12522969 | 1 | Breast cancer |
| 125229692 | 12522969 | 2 | Product used for unknown indication |
| 125229692 | 12522969 | 3 | Product used for unknown indication |
| 125229692 | 12522969 | 4 | Diabetes mellitus |
| 125229692 | 12522969 | 5 | Hypertension |
| 125229692 | 12522969 | 6 | Product used for unknown indication |
| 125229692 | 12522969 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125229692 | 12522969 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125229692 | 12522969 | Blood count abnormal | |
| 125229692 | 12522969 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125229692 | 12522969 | 1 | 201506 | 0 | ||
| 125229692 | 12522969 | 3 | 20160618 | 0 |